Pyrazine compounds and uses as PI3K inhibitors

Details Pyrazine compounds and uses as PI3K inhibitors Pyrazine compounds and uses as PI3K inhibitors

2006-08-25

2011-12-06

Murray, Jeffrey (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S353000

Reexamination Certificate

active

08071597

ABSTRACT:
The present invention is related to pyrazine derivatives of Formula (I) in particular for the treatment and/or prophylaxis of autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer, transplantation, graft rejection or lung injuries.

REFERENCES:
patent: WO 03/035075 (2003-05-01), None
Litvinenkov, et. al., Chemistry of Heterocyclic Compounds (1994), 30(3), 340-44.
Accession No. 2005:3916002 CHEMCATS, Catalog Name, Ambinter Stock Screening Collection, Jul. 3, 2005, XP-002360554, pp. 1-3.
Hui, A. et al. “Substituent effect of camphor sulfonamide ligand on the asymmetric addition of diethylzinc to aldehyde”ARKIVOC, 2006, pp. 41-56, vol. XIII.

Affiliated with

Also associated with

Rating

Pyrazine compounds and uses as PI3K inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazine compounds and uses as PI3K inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazine compounds and uses as PI3K inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4293565